Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 54/100

Termination Rate

22.2%

2 terminated out of 9 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results67% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (4)
P 2 (1)
P 3 (1)
P 4 (3)

Trial Status

Completed4
Withdrawn2
Terminated2
Recruiting1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (9)

Research Network

Activity Timeline